AAAAAA

   
Results: 1-8 |
Results: 8
Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: Importance of monitoring for WT1-mRNA quantitatively
Authors: Sakatani, T Shimazaki, C Hirai, H Okano, A Hatsuse, M Okamoto, A Takahashi, R Ashihara, E Inaba, T Yokota, H Nakahara, K Hirai, H Nakagawa, M
Citation: T. Sakatani et al., Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: Importance of monitoring for WT1-mRNA quantitatively, LEUK LYMPH, 42(1-2), 2001, pp. 225-229
Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): Comparison of CD5(+) with CD5(-) B-LAHS
Authors: Shimazaki, C Inaba, T Okano, A Hatsuse, M Takahashi, R Hirai, H Sudo, Y Ashihara, E Adachi, Y Murakami, S Saigo, K Tsuda, H Fujita, N Nakagawa, M
Citation: C. Shimazaki et al., Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): Comparison of CD5(+) with CD5(-) B-LAHS, INTERN MED, 40(9), 2001, pp. 878-882
Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndrome
Authors: Hirai, H Shimazaki, C Hatsuse, M Okano, A Ashihara, E Inaba, T Murakami, S Saigo, K Nakagawa, M
Citation: H. Hirai et al., Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndrome, LEUKEMIA, 15(2), 2001, pp. 311-312
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation
Authors: Okano, A Shimazaki, C Ochiai, N Hatsuse, M Takahashi, R Ashihara, E Inaba, T Fujita, N Noda, Y Nakagawa, M
Citation: A. Okano et al., Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation, BONE MAR TR, 28(7), 2001, pp. 709-711
Clinicopathological features of myeloid/natural killer (NK) cell precursoracute leukemia
Authors: Inaba, T Shimazaki, C Sumikuma, T Ochiai, N Okano, A Hatsuse, M Ashihara, E Kobayashi, Y Rin, K Murakami, S Haruyama, H Fujita, N Nakagawa, M
Citation: T. Inaba et al., Clinicopathological features of myeloid/natural killer (NK) cell precursoracute leukemia, LEUK RES, 25(2), 2001, pp. 109-113
A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells
Authors: Takahashi, R Shimazaki, C Inaba, T Okano, A Hatsuse, M Okamoto, A Hirai, H Ashihara, E Nakagawa, M
Citation: R. Takahashi et al., A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells, LEUK RES, 25(1), 2001, pp. 77-83
Feasibility and efficacy of high-dose etoposide followed by low-dose granulocyte colony-stimulating factor as a mobilization regimen in patients withnon-Hodgkin's lymphoma
Authors: Ashihara, E Shimazaki, C Okano, A Hatsuse, M Inabe, T Nakagawa, M
Citation: E. Ashihara et al., Feasibility and efficacy of high-dose etoposide followed by low-dose granulocyte colony-stimulating factor as a mobilization regimen in patients withnon-Hodgkin's lymphoma, HAEMATOLOG, 85(10), 2000, pp. 1112-1114
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma
Authors: Inaba, T Shimazaki, C Sumikuma, T Okano, A Hatsuse, M Okamoto, A Takahashi, R Ashihara, E Hibi, S Sudo, Y Yamagata, N Murakami, S Rin, K Fujita, N Yoshimura, M Nakagawa, M
Citation: T. Inaba et al., Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma, BR J HAEM, 109(3), 2000, pp. 592-599
Risultati: 1-8 |